Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05443659 · ClinicalTrials.gov registry record
Real-world Data Analysis of REN Treatment in Adolescence With Migraine
A clinical trial, sponsored by Theranica.
- Completed
- Registry status
- 1,629
- Enrollment target
NCT05443659 is a clinical trial that has completed, run by Theranica. The registered enrollment target is 1,629 participants.
The verdict
NCT05443659 has completed, sponsored by Theranica.
- COMPLETED
- Registry status
- 1,629 participants
- Enrollment target
Study Summary
This is a Post-marketing study investigating the safety and efficacy of the REN device (Nerivio by Theranica, Israel) in adolescents with migraine. Data analysis concerning the REN treatment efficacy in terms of pain and functional disability as a standalone treatment or in combination with other medications will be performed.
Interventions
- DEVICE Nerivio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,629 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2022-08-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05443659
The ClinicalTrials.gov registry entry for NCT05443659 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,629 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Theranica, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nerivio is the first listed.
NCT05443659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05443659 about?
NCT05443659 is a clinical study titled "Real-world Data Analysis of REN Treatment in Adolescence With Migraine". This is a Post-marketing study investigating the safety and efficacy of the REN device (Nerivio by Theranica, Israel) in adolescents with migraine. Data analysis concerning the REN treatment efficacy in terms of pain and functional disability as a standalone treatment or in combination with other me...
What is the current status of trial NCT05443659?
This trial is currently completed. The enrollment target is 1,629 participants. The study started on 2021-01-01. Estimated completion is 2022-08-24.
What interventions are being tested in trial NCT05443659?
The interventions under investigation include: Nerivio (DEVICE).
Who is sponsoring clinical trial NCT05443659?
This trial is sponsored by Theranica, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.